[1] |
Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, classification and diagnosis of diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2019, 127:S1-S7.
|
[2] |
成海梅, 张利, 陈香美. 糖尿病肾病与糖尿病视网膜病变的相关性研究进展[J]. 中华肾病研究电子杂志, 2019,8:85-90.
|
[3] |
刘辰, 方思尹, 顾操, 等.抗视网膜脉络膜新生血管性疾病治疗药物靶点的研究进展[J].基础医学与临床,2022,42:325-329.
|
[4] |
Zimmermann N, Knief J, Kacprowski T, et al. MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases[J]. Oncotarget, 2018,9:28379-28390.
|
[5] |
陈向武,赵颖熙.基因治疗与眼部纤维化疾病[J].基础医学与临床,2014,34:1289-1292.
|
[6] |
剌梅, 李江, 孙继红, 等. 血清miRNA-146、miRNA-195检测在糖尿病视网膜病变中的临床应用[J]. 临床和实验医学杂志, 2017,12:113-120.
|
[7] |
刁雪红, 申锷, 胡兵, 等. 糖尿病小鼠心肌组织microRNA表达谱分析[J]. 上海交通大学学报(医学版), 2016,10:20-24.
|
[8] |
Meng L, Li G, Liu X, et al. Decreased urine miR-199-3p may be a potential biomarker for diabetic nephropathy via targeting zinc finger e-box-binding protein 1[J]. Clin Lab, 2018, 64: 1177-1182.
|
[9] |
Joao PWC, Manuel BR, Denise HK, et al. Glucose stimulates microRNA-199 expression in murine pancreatic β-cells[J]. J Biol Chem, 2020, 295: 1261-1270.
|
[10] |
Wang JJ, Wu KF, Wang DD.A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy[J]. Can J Physiol Pharmacol, 2021, 99:1175-1183.
|
[11] |
Huang X, Liang P, Jiang B, et al. Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis[J]. Life Sci, 2020, 259: 118246-118269. doi: 10.1016/j.lfs.2020.118246.
|
[12] |
宋鄂, 徐琪, 王心蕊, 等. 血管内皮生长因子在糖尿病大鼠视网膜中的表达[J]. 吉林大学学报(医学版), 2017,1:43-45.
|
[13] |
Wang L, Liu WX, Huang XG.MicroRNA-199-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy[J]. Exp Mol Pathol, 2020, 116:104488-104503.doi: 10.1016/j.yexmp.2020.104488.
|
[14] |
Wang W, Ann C, Yu Q, et al. Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush[J]. Exp Eye Res, 2016,140:1-9.
|
[15] |
Pan W, Pham VN, Stratman AN, et al. CDP-diacylglyce-rol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis[J]. Blood, 2019,120:489-498.
|